TY - JOUR
T1 - Clinical and electrophysiological features of acute flaccid myelitis
T2 - A national cohort study
AU - for the Acute Flaccid Myelitis Collaborative Study Investigators
AU - Chong, Pin Fee
AU - Torisu, Hiroyuki
AU - Yasumoto, Sawa
AU - Okumura, Akihisa
AU - Mori, Harushi
AU - Sato, Tatsuharu
AU - Kimura, Jun
AU - Ohga, Shouichi
AU - Tanaka-Taya, Keiko
AU - Kira, Ryutaro
N1 - Funding Information:
Members of the Acute Flaccid Myelitis Collaborative Study Investigators are as follows: Sonoko Kubota, Nihon University Itabashi Hospital; Etsushi Toyofuku, Saitama Citizens Medical Center; Tetsuhiro Fukuyama, Nagano Children's Hospital; Mari Asaoka, Nagano Municipal Hospital; Kengo Moriyama, Tokyo Medical and Dental University; Takako Fujita, Fukuoka University Hospital; Tamami Yano, Akita University Hospital; Mariko Kasai, The University of Tokyo Hospital; Yuya Takahashi, Nagaoka Red Cross Hospital; Takashi Uchida, Masashi Fujita, Hachinohe City Hospital; Atsuko Hata, Hideto Ogata, Kitano Hospital, Tazuke Kofukai Medical Research Institute; Yu Ishida, Tokyo Medical University Hospital; Eri Takeshita, National Center Hospital, National Center of Neurology and Psychiatry; Takayoshi Kawabata, Ishikawa Prefectural Central Hospital; Chiharu Miyatake, Nippon Medical School Chiba Hokusoh Hospital; Masato Hiyane, Okinawa Prefectural Southern Medical Center and Children's Medical Center; Yuichi Abe, Michiaki Nagura, Hideo Yamanouchi, Saitama Medical University; Satomi Mori, Matsue Red Cross Hospital; Yumiko Takashima, Kazushi Ichikawa, Kanagawa Children's Medical Center; Nobuko Moriyama, Hitachi, Ltd. Hitachinaka General Hospital; Akane Kanazawa, Kochi Health Sciences Center; Sosuke Yoshikawa, Osaka Rosai Hospital; Kenichi Tanaka, Fujita Health University; Genrei Ohta, University of Fukui Hospital; Ayako Hattori, Nagoya City University Hospital; Sahoko Ono, Kasawaki Medical School Hospital; Tomoshige Tanimura, Kyoko Ban, Yokkaichi Municipal Hospital; Nobuyoshi Sugiyama, Tokai University; Nozomi Kouzan, Japanese Red Cross Society Kyoto Daiichi Hospital; Takao Fukushima, Niigata Prefectural Shibata Hospital; Kenichi Sakajiri, National Hospital Organization Kanazawa Medical Center; Miho Yamamuro, Japan Community Health Care Organization Osaka Hospital; Taira Toki, Kitasato University; Ayako Yamamoto, Saiseikai Yokohamashi Tobu Hospital; Ryota Sato, Kanmon Medical Center; Yu Kakimoto, Hiroshi Terashima, Masaya Kubota, National Center for Child Health and Development; Sakiko Mabuchi, Yoko Shida, Tokyo Women's Medical University Medical Center East; Naru Igarashi, Noboru Yoshida, Juntendo University Nerima Hospital; Ryoko Hayashi, Osaka Medical Center, and Research Institute for Maternal and Child Health. This study was supported by the Ministry of Health, Labour and Welfare of Japan (19HA1002), the Japan Society for the Promotion of Science (JSPS KAKENHI JP19K10613), Grant of The Clinical Research Promotion Foundation 2017, and Fukuoka Children's Research Fund.
Funding Information:
This study was supported by the Ministry of Health, Labour and Welfare of Japan (19HA1002), the Japan Society for the Promotion of Science (JSPS KAKENHI JP19K10613), Grant of The Clinical Research Promotion Foundation 2017, and Fukuoka Children’s Research Fund.
Publisher Copyright:
© 2021 International Federation of Clinical Neurophysiology
PY - 2021/10
Y1 - 2021/10
N2 - Objective: To summarize the neurophysiological properties of acute flaccid myelitis (AFM) and evaluate limb-based motor outcomes. Methods: Nerve conduction studies (NCS) in 49 patients (21 females, 28 males; median age = 52 m) with AFM (median = 7 d after onset; range 1–122 d) were reviewed. Neurophysiological findings, together with treatment and prognosis, and neurophysiology–neuroimaging correlations were analyzed. Results: The findings indicated that 64% of paralytic limbs during the acute stage (≤14 d after onset) showed diminished or absent compound muscle action potentials (CMAPs), 79% showed normal motor nerve conduction velocities, 55% showed decreased persistence or absent F-waves, and 95% showed normal sensory nerve conduction velocities. The rate of CMAP abnormalities increased from 41% on days 1–2 to 83% on days 13–14. The reduction in CMAP amplitude was correlated with weaker muscle strength at both the peak neurological deficit and the last follow-up. The baseline limb-based muscle strength at nadir and anterior horn-localized magnetic resonance imaging lesions at recovery stage (>14 d) were strong predictors of outcome at the last follow-up. Conclusions: AFM typically shows neurophysiological features of neuronopathy. Significance: NCS is probably useful in the diagnosis and evaluation of AFM.
AB - Objective: To summarize the neurophysiological properties of acute flaccid myelitis (AFM) and evaluate limb-based motor outcomes. Methods: Nerve conduction studies (NCS) in 49 patients (21 females, 28 males; median age = 52 m) with AFM (median = 7 d after onset; range 1–122 d) were reviewed. Neurophysiological findings, together with treatment and prognosis, and neurophysiology–neuroimaging correlations were analyzed. Results: The findings indicated that 64% of paralytic limbs during the acute stage (≤14 d after onset) showed diminished or absent compound muscle action potentials (CMAPs), 79% showed normal motor nerve conduction velocities, 55% showed decreased persistence or absent F-waves, and 95% showed normal sensory nerve conduction velocities. The rate of CMAP abnormalities increased from 41% on days 1–2 to 83% on days 13–14. The reduction in CMAP amplitude was correlated with weaker muscle strength at both the peak neurological deficit and the last follow-up. The baseline limb-based muscle strength at nadir and anterior horn-localized magnetic resonance imaging lesions at recovery stage (>14 d) were strong predictors of outcome at the last follow-up. Conclusions: AFM typically shows neurophysiological features of neuronopathy. Significance: NCS is probably useful in the diagnosis and evaluation of AFM.
UR - http://www.scopus.com/inward/record.url?scp=85113377292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113377292&partnerID=8YFLogxK
U2 - 10.1016/j.clinph.2021.07.013
DO - 10.1016/j.clinph.2021.07.013
M3 - Article
C2 - 34454273
AN - SCOPUS:85113377292
SN - 1388-2457
VL - 132
SP - 2456
EP - 2463
JO - Clinical Neurophysiology
JF - Clinical Neurophysiology
IS - 10
ER -